Literature DB >> 9481410

Abdominal aortic aneurysms and malignant neoplasia: double jeopardy.

R J Valentine1, A S Pearson, D D McIntire, R T Hagino, R H Turnage, G P Clagett.   

Abstract

BACKGROUND: This study was performed to determine whether there is a significant association between abdominal aortic aneurysms (AAAs) and malignancy and to determine the impact of malignancy on late survival in patients with AAA.
METHODS: We studied 126 men undergoing AAA repair and compared them with 99 men undergoing aortofemoral bypass (AFB) for occlusive disease and with 100 men undergoing herniorrhaphy during the same period.
RESULTS: Fifty-one (40%) patients with AAA, 23 (23%) patients undergoing AFB, and 21 (21%) patients undergoing herniorrhaphy were diagnosed with cancer (p = 0.002). By life table analysis the proportion of subjects remaining cancer free at 5 years was 0.60 +/- 0.05 for AAA, 0.83 +/- 0.04 for AFB, and 0.81 +/- 0.04 for herniorrhaphy (p = 0.004). Multivariate analysis selected four independent risk factors for cancer: presence of AAA (p = 0.003, odds ratio 1.4, confidence interval [CI] 1.2 to 1.7), age (p = 0.001, odds ratio per year 1.1, CI 1.0 to 1.1), smoking (p = 0.04, odds ratio 1.5, CI 1.0 to 2.2), and hypertension (p = 0.04, odds ratio 0.73, CI 0.5 to 1.0). Cancer deaths accounted for 32% of late deaths in patients with AAA, which was not different compared with 26% of late deaths in patients undergoing AFB and 36% of late deaths in patients undergoing herniorrhaphy. Five-year cancer-free survival was 0.44 +/- 0.05 for patients with AAA, 0.64 +/- 0.05 for patients undergoing AFB, and 0.70 +/- 0.05 for patients undergoing herniorrhaphy (p < 0.001, AAA versus herniorrhaphy only).
CONCLUSIONS: Cancer is more prevalent in men with AAA than in men undergoing AFB or herniorrhaphy. The presence of AAA appears to be an independent risk factor for cancer. Despite the higher cancer prevalence in patients with AAA, cardiovascular disease accounted for the largest number of late deaths in this series, minimizing differences in cancer-free survival between patients with AAA and patients undergoing AFB.

Entities:  

Mesh:

Year:  1998        PMID: 9481410

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  5 in total

1.  Management of concurrent colorectal cancer and vascular disease in the endovascular era.

Authors:  C P Spanos; G Tsoulfas; G Georgantis; N Melas; N Saratzis; K Ktenidis; I Lazaridis; A Mekras; T Syrakos; D Kiskinis
Journal:  Tech Coloproctol       Date:  2011-10       Impact factor: 3.781

2.  Treatment of abdominal aortic aneurysm associated with colorectal cancer: presentation of 14 cases and literature review.

Authors:  G F Veraldi; A M Minicozzi; F Leopardi; V Ciprian; B Genco; R Pacca
Journal:  Int J Colorectal Dis       Date:  2008-04       Impact factor: 2.571

3.  Peripheral arterial disease and systematic detection of circulating tumor cells: rationale and design of the DETECTOR prospective cohort study.

Authors:  Alexandra Yannoutsos; Manon Fontaine; Alexandre Galloula; Diane Damotte; Gilles Chatellier; Patrizia Paterlini-Bréchot; Guy Meyer; Jean Pastre; Véronique Duchatelle; Valéria Marini; Karl-Léo Schwering; Isabelle Lazareth; Parinaz Ghaffari; Audrey Stansal; Hélène Sanson; Cécile Labrousse; Hélène Beaussier; Nesrine Ben Nasr; Marc Zins; Sergio Salmeron; Emmanuel Messas; Jean-Patrick Lajonchère; Joseph Emmerich; Pascal Priollet; Jean Trédaniel
Journal:  BMC Cardiovasc Disord       Date:  2019-09-13       Impact factor: 2.298

4.  Outcomes after aortic aneurysm repair in patients with history of cancer: a nationwide dataset analysis.

Authors:  Sanghyun Ahn; Jin-Young Min; Hyunyoung G Kim; Hyejin Mo; Seung-Kee Min; Sangil Min; Jongwon Ha; Kyoung-Bok Min
Journal:  BMC Surg       Date:  2020-05-01       Impact factor: 2.102

5.  Association Between Obesity and Cancer Mortality: An Internal Medicine Outpatient Clinic Perspective.

Authors:  Vede Ramdass; Elizabeth Caskey; Tammarah Sklarz; Saaniya Ajmeri; Vaishali Patel; Ayobamidele Balogun; Victor Pomary; Jillian Hall; Omar Qari; Rahul Tripathi; Krystal Hunter; Satyajeet Roy
Journal:  J Clin Med Res       Date:  2021-07-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.